Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 6:38 pm Sale | 2024-12-31 | 13G | GlycoMimetics, Inc. GLYC | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -6,383,000 (Position Closed) | Filing History |
| 2024-11-27 2:22 pm Purchase | 2024-11-25 | 13G | GlycoMimetics, Inc. GLYC | Logos Global Management LP | 5,000,000 7.800% | 5,000,000 (New Position) | Filing History |
| 2024-11-12 4:30 pm Sale | 2024-09-30 | 13G | GlycoMimetics, Inc. GLYC | Invus Global Management LLC | 1,965,114 3.000% | -3,323,394 (-62.84%) | Filing History |
| 2024-11-06 5:41 pm Purchase | 2024-10-30 | 13G | GlycoMimetics, Inc. GLYC | RA CAPITAL MANAGEMENT L.P. | 6,383,000 9.900% | 6,383,000 (New Position) | Filing History |
| 2024-11-04 4:26 pm Purchase | 2024-10-29 | 13D | GlycoMimetics, Inc. GLYC | Adage Capital Management L.P. | 5,091,231 7.900% | 5,091,231 (New Position) | Filing History |
| 2024-11-04 2:01 pm Sale | 2024-10-30 | 13G | GlycoMimetics, Inc. GLYC | Weinstein Benjamin | 50,000 0.100% | -3,353,931 (-98.53%) | Filing History |
| 2024-08-15 5:01 pm Sale | 2024-08-13 | 13G | GlycoMimetics, Inc. GLYC | Invus Global Management LLC | 5,288,508 8.200% | -3,300,556 (-38.43%) | Filing History |
| 2024-08-14 4:13 pm Purchase | 2024-08-09 | 13G | GlycoMimetics, Inc. GLYC | Weinstein Benjamin | 3,403,931 5.300% | 3,403,931 (New Position) | Filing History |
| 2024-07-29 7:24 pm Purchase | 2024-07-25 | 13G | GlycoMimetics, Inc. GLYC | Invus Global Management LLC | 8,589,064 13.300% | 8,589,064 (New Position) | Filing History |
| 2024-05-08 5:06 pm Sale | 2024-05-06 | 13D | GlycoMimetics, Inc. GLYC | NEW ENTERPRISE ASSOCIATES 10 L P | 2,181,892 5.000% | -1,826,085 (-45.56%) | Filing History |
| 2024-02-29 7:28 pm Sale | 2024-02-06 | 13D | GlycoMimetics, Inc. GLYC | NEW ENTERPRISE ASSOCIATES 10 L P | 4,007,977 6.200% | -713,899 (-15.12%) | Filing History |
| 2024-02-12 4:48 pm Sale | 2024-02-06 | 13D | GlycoMimetics, Inc. GLYC | NEW ENTERPRISE ASSOCIATES 10 L P | 4,721,876 7.300% | -245,654 (-4.95%) | Filing History |
| 2024-02-09 5:03 pm Purchase | 2023-12-31 | 13G | GlycoMimetics, Inc. GLYC | Artal International S.C.A. | 8,589,064 13.300% | 2,015,266 (+30.66%) | Filing History |
| 2024-01-29 4:31 pm Unchanged | 2023-03-29 | 13G | GlycoMimetics, Inc. GLYC | BIOTECHNOLOGY VALUE FUND LP | 9,544,262 14.800% | 0 (Unchanged) | Filing History |
| 2023-02-13 5:18 pm Purchase | 2023-02-09 | 13G | GlycoMimetics, Inc. GLYC | Artal International S.C.A. | 6,573,798 12.500% | 6,573,798 (New Position) | Filing History |
| 2023-02-10 5:23 pm Sale | 2023-01-26 | 13D | GlycoMimetics, Inc. GLYC | NEW ENTERPRISE ASSOCIATES 10 L P | 4,967,530 9.500% | -4,143,797 (-45.48%) | Filing History |
| 2022-02-10 08:11 am Sale | 2021-12-31 | 13G | GlycoMimetics, Inc. GLYC | The Vanguard Group | 2,238,553 4.330% | -330,686 (-12.87%) | Filing History |
| 2021-07-12 08:29 am Sale | 2021-06-30 | 13G | GlycoMimetics, Inc. GLYC | BlackRock Inc. BLK | 886,148 1.700% | -1,730,329 (-66.13%) | Filing History |
| 2021-02-16 08:24 am Sale | 2020-12-31 | 13G | GlycoMimetics, Inc. GLYC | Camber Capital Management LP | 2,200,000 4.600% | -1,300,000 (-37.14%) | Filing History |
| 2021-02-12 3:42 pm Sale | 2020-12-31 | 13G | GlycoMimetics, Inc. GLYC | EcoR1 Capital, LLC | 0 0.000% | -2,909,800 (Position Closed) | Filing History |